SHZ · Financial Statements

Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) Financial Statements

$4.01 SHZ: 002793.SZ Market Cap $4.89B

Full income statement, balance sheet, and cash flow statement for Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA90.92
FCF Yield—
Quick Ratio0.60
Interest Coverage—
Return 1Y-24.48%
Return 3Y-30.98%
Return 5Y-56.71%

Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) financials — frequently asked questions

What is 002793.SZ EV/EBITDA?

Luoxin Pharmaceuticals Group Stock Co., Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is 90.92.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
002793.SZ Overview 002793.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.